Drug discovery todayHumansClinical Trials as TopicDrug DevelopmentForecastingDrug Industry
Forecasting clinical trial success using anonymized external expert panels.
Frank S David, R Edward Benson, Mark Gordon, Daniel S Mytelka
Published: 202510.1016/j.drudis.2025.104525
Abstract
Drug developers and financial investors have substantial interest in making accurate forecasts of the probability of success (POS) of clinical trials. Current methods developed and used by pharmaceutical companies face challenges in optimizing for ac…
Preview only. Read the full abstract at the source